Koninklijke Philips Revenue 2010-2023 | PHG
Koninklijke Philips annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Koninklijke Philips revenue for the quarter ending September 30, 2023 was $4.866B, a 4.52% decline year-over-year.
- Koninklijke Philips revenue for the twelve months ending September 30, 2023 was $18.658B, a 8.09% decline year-over-year.
- Koninklijke Philips annual revenue for 2023 was $19.664B, a 4.69% increase from 2022.
- Koninklijke Philips annual revenue for 2022 was $18.783B, a 7.46% decline from 2021.
- Koninklijke Philips annual revenue for 2021 was $20.297B, a 9.04% decline from 2020.
| Koninklijke Philips Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $19,664 |
| 2022 | $18,783 |
| 2021 | $20,297 |
| 2020 | $22,315 |
| 2019 | $21,820 |
| 2018 | $21,401 |
| 2017 | $20,097 |
| 2016 | $27,129 |
| 2015 | $26,921 |
| 2014 | $28,435 |
| 2013 | $30,988 |
| 2012 | $31,880 |
| 2011 | $31,448 |
| 2010 | $33,756 |
| 2009 | $32,339 |
| Koninklijke Philips Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-09-30 | $4,866 |
| 2023-06-30 | $4,874 |
| 2023-03-31 | $4,473 |
| 2022-06-30 | $4,445 |
| 2021-06-30 | $5,097 |
| 2020-06-30 | $4,839 |
| 2019-06-30 | $5,250 |
| 2018-06-30 | $5,114 |
| 2017-06-30 | $4,724 |
| 2016-12-31 | $7,842 |
| 2016-09-30 | $6,579 |
| 2016-06-30 | $6,622 |
| 2016-03-31 | $6,086 |
| 2015-12-31 | $7,793 |
| 2015-09-30 | $6,493 |
| 2015-06-30 | $6,608 |
| 2015-03-31 | $6,026 |
| 2014-12-31 | $6,934 |
| 2014-09-30 | $7,360 |
| 2014-06-30 | $7,261 |
| 2014-03-31 | $6,880 |
| 2013-12-31 | $9,217 |
| 2013-09-30 | $7,442 |
| 2013-06-30 | $7,384 |
| 2013-03-31 | $6,945 |
| 2012-12-31 | $9,640 |
| 2012-09-30 | $7,995 |
| 2012-06-30 | $7,188 |
| 2012-03-31 | $7,364 |
| 2011-12-31 | $8,799 |
| 2011-09-30 | $7,447 |
| 2011-06-30 | $7,502 |
| 2011-03-31 | $7,583 |
| 2010-12-31 | $10,061 |
| 2010-09-30 | $7,945 |
| 2010-06-30 | $7,900 |
| 2010-03-31 | $7,868 |
| 2009-12-31 | $10,727 |
| 2009-09-30 | $8,108 |
| 2009-06-30 | $7,441 |
| 2009-03-31 | $6,638 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $19.139B | $19.663B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.786B | 24.39 |
| Stryker (SYK) | United States | $124.672B | 30.91 |
| Medtronic (MDT) | Ireland | $106.983B | 15.15 |
| Boston Scientific (BSX) | United States | $99.792B | 33.18 |
| EssilorLuxottica (ESLOY) | France | $98.590B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.472B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.173B | 29.86 |
| ResMed (RMD) | United States | $26.527B | 26.52 |
| Terumo (TRUMY) | Japan | $25.252B | 35.66 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.816B | 15.98 |
| Baxter (BAX) | United States | $20.516B | 14.96 |
| Insulet (PODD) | United States | $11.513B | 60.45 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.649B | 0.00 |
| Demant (WILYY) | Denmark | $9.853B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.989B | 23.80 |
| BellRing Brands (BRBR) | United States | $7.214B | 38.79 |
| Lantheus Holdings (LNTH) | United States | $4.324B | 11.16 |
| Haemonetics (HAE) | United States | $4.247B | 21.72 |
| Perrigo (PRGO) | Ireland | $4.074B | 11.65 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.466B | 16.39 |
| Envista Holdings (NVST) | United States | $3.456B | 13.14 |
| QuidelOrtho (QDEL) | United States | $2.614B | 9.49 |
| Neogen (NEOG) | United States | $2.552B | 24.54 |
| Green Thumb Industries (GTBIF) | United States | $2.526B | 80.07 |
| ICU Medical (ICUI) | United States | $2.348B | 17.52 |
| TG Therapeutics (TGTX) | United States | $2.179B | 705.00 |
| Owens & Minor (OMI) | United States | $1.856B | 17.82 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.853B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.698B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.652B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.444B | 44.98 |
| InMode (INMD) | Israel | $1.439B | 7.45 |
| LeMaitre Vascular (LMAT) | United States | $1.409B | 46.50 |
| AdaptHealth (AHCO) | United States | $1.276B | 9.60 |
| Warby Parker (WRBY) | United States | $1.218B | 0.00 |
| AtriCure (ATRC) | United States | $1.099B | 0.00 |
| MacroGenics (MGNX) | United States | $0.964B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.761B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.715B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.97 |
| Cresco Labs (CRLBF) | United States | $0.684B | 0.00 |
| Evolus (EOLS) | United States | $0.679B | 0.00 |
| Quanterix (QTRX) | United States | $0.623B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Jin Medical (ZJYL) | China | $0.532B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.529B | 11.45 |
| PetIQ (PETQ) | United States | $0.486B | 18.14 |
| TerrAscend (TSNDF) | Canada | $0.475B | 0.00 |
| ZimVie (ZIMV) | United States | $0.422B | 25.82 |
| Biote (BTMD) | United States | $0.414B | 3.94 |
| OraSure Technologies (OSUR) | United States | $0.409B | 6.77 |
| Surmodics (SRDX) | United States | $0.361B | 39.06 |
| Zynex (ZYXI) | United States | $0.358B | 41.26 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
| Cerus (CERS) | United States | $0.306B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.304B | 30.15 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.245B | 14.91 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Veru (VERU) | United States | $0.186B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
| Omeros (OMER) | United States | $0.178B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.133B | 66.92 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.77 |
| Jushi Holdings (JUSHF) | United States | $0.127B | 0.00 |
| InterCure (INCR) | Israel | $0.115B | 19.46 |
| Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.80 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.079B | 0.00 |
| Safety Shot (SHOT) | United States | $0.077B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.52 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |